Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	101857
Country	China

Received	2024-09-28 15:41
Peer-Review Started	2024-09-28 15:41
To Make the First Decision
Return for Revision	2024-11-11 07:36
Revised	2024-11-23 15:53
Second Decision	2024-12-20 03:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-20 06:27
Articles in Press	2024-12-20 06:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-01-22 04:09
Publish the Manuscript Online	2025-02-14 10:33

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Letter to the Editor
Article Title	Exosome technology: A novel and effective drug delivery system in the field of cancer therapy
Manuscript Source	Unsolicited Manuscript
All Author List	Jia-Xin Geng, Yao-Fan Lu, Jing-Nan Zhou, Biao Huang and Yuan Qin
ORCID	Author(s) ORCID Number Biao Huang http://orcid.org/0000-0003-1883-0670 Yuan Qin http://orcid.org/0000-0002-5651-8293
Funding Agency and Grant Number	Funding Agency Grant Number the Natural Science Foundation of Zhejiang Province LQ23H050005 Zhejiang Medical and Health Science and Technology Project 2023KY615 Scientific research project of Zhejiang Provincial Education Department Y202250731 and Y202353130 the China Students’ Innovation and Entrepreneurship Training Program 202310338044 China Postdoctoral Science Foundation 2022M721720
Corresponding Author	Yuan Qin, Associate Professor, PhD, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, No. 928 Second Avenue, Qiantang District, Hangzhou 310018, Zhejiang Province, China. qinyuan@zstu.edu.cn
Key Words	Exosomes; Drug delivery; Mesenchymal stem cells; Tumor therapy; Gemcitabine
Core Tip	The biocompatibility, targeting specificity, and low immunogenicity of exosomes render them as optimal carriers for drug delivery, enabling precise administration of therapeutics to diseased tissues, thereby achieving targeted treatment of cancer cells. However, the clinical application of exosome drug delivery platforms in oncology still presents challenges, necessitating further optimization to ensure their stability and efficacy. This study focuses on elucidating the advantages of exosomes as a drug delivery platform, exploring the utilization of mesenchymal stem cell-derived exosomes in oncology therapy, and discussing their potential and future directions in cancer treatment.
Publish Date	2025-02-14 10:33
Citation	<p>Geng JX, Lu YF, Zhou JN, Huang B, Qin Y. Exosome technology: A novel and effective drug delivery system in the field of cancer therapy. <i>World J Gastrointest Oncol</i> 2025; 17(3): 101857</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i3/101857.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i3.101857

Full Article (PDF)	WJGO-17-101857-with-cover.pdf
Manuscript File	101857_Auto_Edited_011823.docx
Answering Reviewers	101857-answering-reviewers.pdf
Audio Core Tip	101857-audio.wav
Conflict-of-Interest Disclosure Form	101857-conflict-of-interest-statement.pdf
Copyright License Agreement	101857-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	101857-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	101857-non-native-speakers.pdf
Peer-review Report	101857-peer-reviews.pdf
Scientific Misconduct Check	101857-scientific-misconduct-check.png
Scientific Editor Work List	101857-scientific-editor-work-list.pdf
CrossCheck Report	101857-crosscheck-report.pdf